Mikkel Jürgens

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 2

Top Topics

Replacement Therapy

Glycemic Control

Placebo Controlled

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

Herlev Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Herlev Hospital Aug 01 2016

Denmark

M.D, Clinical Research Assistant :: Internal Medicine

Publications

Mikkel Jürgens, Morten Schou, Philip Hasbak, Andreas Kjaer, Emil Wolsk, Bo Zerahn, Niels Høegh Brandt-Jacobsen, Peter Haulund Gaede, Ellen Burgess, Jens Faber, Silvio E Inzucchi, Finn Gustafsson, Caroline Kistorp
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes. Diabetes, obesity & metabolism (2023)
Mikkel Jürgens, Morten Schou, Philip Hasbak, Andreas Kjær, Emil Wolsk, Bo Zerahn, Mikkel Wiberg, Niels Høgh Brandt, Peter Haulund Gæde, Peter Rossing, Jens Faber, Silvio Inzucchi, Finn Gustafsson, Caroline Michaela Kistorp
Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial). BMJ open 9 (11) (2019)